Cover Image

Association between socioeconomic and psychosocial factors with use of interventional and surgical treatments and outcomes in patients with myocardial infarction: inpatient data of the largest European health care system

Background - Myocardial infarction (MI) is an important driver of both morbidity and mortality on a global scale. Elucidating social inequalities may help to identify vulnerable groups as well as treatment imbalances and guide efforts to improve care for MI. - Methods - All hospitalized patient-case...

Full description

Saved in:
Bibliographic Details
Main Authors: Hahad, Omar (Author) , Hobohm, Lukas (Author) , Al-Kindi, Sadeer (Author) , Schmitt, Volker H. (Author) , Kazemi-Asrar, Fawad (Author) , Gilan, Donya (Author) , Petrowski, Katja (Author) , Gori, Tommaso (Author) , Wild, Philipp (Author) , Lieb, Klaus (Author) , Daiber, Andreas (Author) , Lurz, Philipp (Author) , Münzel, Thomas (Author) , Keller, Karsten (Author)
Format: Article (Journal)
Language:English
Published: October 2024
In: European journal of internal medicine
Year: 2024, Volume: 128, Pages: 71-80
ISSN:1879-0828
DOI:10.1016/j.ejim.2024.05.032
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.ejim.2024.05.032
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S0953620524002371
Get full text
Author Notes:Omar Hahad, Lukas Hobohm, Sadeer Al-Kindi, Volker H. Schmitt, Fawad Kazemi-Asrar, Donya Gilan, Katja Petrowski, Tommaso Gori, Philipp Wild, Klaus Lieb, Andreas Daiber, Philipp Lurz, Thomas Münzel, Karsten Keller
Description
Summary:Background - Myocardial infarction (MI) is an important driver of both morbidity and mortality on a global scale. Elucidating social inequalities may help to identify vulnerable groups as well as treatment imbalances and guide efforts to improve care for MI. - Methods - All hospitalized patient-cases with confirmed MI 2005-2020 in Germany were included in the study and stratified for socioeconomic or psychosocial factors (SPF) and the impact of SPF on treatment usage and adverse in-hospital events was analyzed. - Results - Overall, 4,409,597 hospitalizations of MI patients were included; of these, 17,297 (0.4 %) were coded with SPF. These patients were more often of female sex (49.4 % vs. 36.9 %, P<0.001), older (median 77.0 [IQR: 65.0-84.0] vs. 73.0 [62.0-81.0] years, P<0.001) and revealed an aggravated cardiovascular profile. Although SPF were independently associated with increased usage of cardiac catheterization (OR 1.174 [95 %CI 1.136-1.212]) and percutaneous coronary intervention (OR 1.167 [95 %CI 1.130-1.205]), they were accompanied by higher risk for a prolonged length of in-hospital stay >7 days (OR 1.236 [95 %CI 1.198-1.276]) and >10 days (OR 1.296 [95 %CI 1.254-1.339]). While SPF were associated with increased risk for deep venous thrombosis and/or thrombophlebitis (OR 1.634 [95 %CI 1.427-1.870]), pulmonary embolism (OR 1.337 [95 %CI 1.149-1.555]), and acute renal failure (OR 1.170 [95 %CI 1.105-1.240), these SPF were inversely associated with in-hospital case-fatality (OR 0.461 [95 %CI 0.433-0.490]). - Conclusions - This study demonstrates that SPF in hospitalized MI patients have significant impacts on treatments and outcomes. Fortunately, our data did not revealed an underuse of interventional treatments in MI patients with SPF.
Item Description:Online verfügbar: 04. Juni 2024, Artikelversion: 01. Oktober 2024
Gesehen am 18.06.2025
Physical Description:Online Resource
ISSN:1879-0828
DOI:10.1016/j.ejim.2024.05.032

Similar Items